Some 25 years ago, a young Parkinson's disease investigator, Robert Hauser, MD, stepped to the podium at an American Academy ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.

A COMMON cough medicine could help protect against dementia. A study found that it prevented people with Parkinson’s develop ...

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...

Understand Parkinson's disease, its symptoms, and the crucial role of clinical trials in treatment and research, especially for Black Americans.

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

About half of those diagnosed with Parkinson's develop dementia within 10 years, profoundly affecting patients, families and the health care system ...

Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...